Skip to main content
OpenTrials

Clinical trial condition

Respiratory Syncytial Virus Infection

Explore clinical trials studying Respiratory Syncytial Virus Infection. Study availability and eligibility vary by location and protocol.

32 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Respiratory Syncytial Virus Infection trial results

Completed

A Multicentre Study in Otherwise Healthy Infants and Toddlers Hospitalised For and Diagnosed With RSV Lower Respiratory Tract Infection to Evaluate the Safety, Tolerability, and Clinical Activity of ALX-0171

NCT02309320

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +5 more
Locations
  • Investigator Site 4 Brisbane, Australia
  • Investigator Site 2 Randwick, Australia
  • Investigator Site 3 Tasmania, Australia
  • Investigator Site 1 Westmead, Australia
View all 59 locations
View Trial Details
Completed

Presatovir in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus (RSV) Infection of the Lower Respiratory Tract

NCT02254421

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +5 more
Locations
  • City of Hope Duarte, California, United States
  • University of Chicago Chicago, Illinois, United States
  • John Hopkins Baltimore, Maryland, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View all 17 locations
View Trial Details
Completed

Efficacy, Pharmacokinetics, and Safety of Presatovir in Hospitalized Adults With Respiratory Syncytial Virus (RSV) Infection

NCT02135614

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +5 more
Locations
  • Northwestern Memorial Hospital Chicago, Illinois, United States
  • Anne Arundel Medical Center Annapolis, Maryland, United States
  • Henry Ford Health System Detroit, Michigan, United States
  • William Beaumont Royal Oak, Michigan, United States
View all 43 locations
View Trial Details
Completed

A One-Year Observation of Palivizumab in Infants at Risk for Respiratory Syncytial Virus Infection in Latin America

NCT01297504

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +5 more
Locations
  • Site Reference ID/Investigator# 52185 Buenos Aires, Argentina
  • Site Reference ID/Investigator# 52182 Buenos Aires, Argentina
  • Site Reference ID/Investigator# 52183 Buenos Aires, Argentina
  • Site Reference ID/Investigator# 52184 Buenos Aires, Argentina
View all 24 locations
View Trial Details
Completed

Clinical Study of Palivizumab in Japanese Newborns, Infants and Young Children at the Age of 24 Months or Less With Immunocompromised Medical Conditions

NCT01466062

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +5 more
Locations
  • Site Reference ID/Investigator# 56847 Hyōgo, Japan
  • Site Reference ID/Investigator# 56845 Shimotsuke, Japan
  • Site Reference ID/Investigator# 56842 Tokyo, Japan
  • Site Reference ID/Investigator# 56844 Tokyo, Japan
View Trial Details
Completed

Effectiveness of Synagis (Palivizumab) Immunoprophylaxis in Preterm Infants With High Risk of Severe Respiratory Syncytial Virus (RSV) Infection

NCT01107535

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +5 more
Locations
  • Site Reference ID/Investigator# 27834 Arequipa, Peru
  • Site Reference ID/Investigator# 6059 Callao, Peru
  • Site Reference ID/Investigator# 27836 Lima, Peru
  • Site Reference ID/Investigator# 27835 Lima, Peru
View Trial Details

Related conditions